Discovery of hepatitis B virus capsid assembly inhibitors leading to a heteroaryldihydropyrimidine based clinical candidate (GLS4)
- Resource Type
- Article
- Source
- In
Bioorganic & Medicinal Chemistry 1 February 2017 25(3):1042-1056 - Subject
- Language
- ISSN
- 0968-0896